Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Jaya Konstruksi Manggala Pratama Tbk (JKON) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Jaya Konstruksi Manggala Pratama TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Jaya Konstruksi Manggala Pratama Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Jaya Konstruksi Manggala Pratama Tbk trades at Rp69 (market cap 1.09T, 1.3M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume). The key difference: Jaya Konstruksi Manggala Pratama Tbk is the larger of the two by market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 1.3M). Which is the better fit depends on your goals.

JKONLABS
Market Cap
1.09T576.7B
Volume
1.3M3.48M
Lot
13.01K34.82K
Turnover
88.78M522.79M
Average Price
68.24150.13
Value
88.78M522.79M
Indicative Equilibrium Price
69148
Indicative Equilibrium Volume
1.9K350

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

JKON
View details
LABS
View details

About Jaya Konstruksi Manggala Pratama Tbk

PT Jaya Konstruksi Manggala Pratama Tbk (the company) was established dated December 23, 1982 based on Notaries Deed No.45 of Hobropoerwanto, SH. The Company’s articles of association has been amended several times, most recently by notarial deed No. 142 of Mr. Aulia Taufani, SH., dated Sep 24, 2007, concerning among others, the change Company’s capital structure and public offering.

Read more on JKON

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS